Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET1 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.007 |
mRNA | HSD17B6 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
mRNA | PM20D2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
mRNA | ZPR1 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.007 |
mRNA | KCNK9 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.007 |
mRNA | EIF4EBP3 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.007 |
mRNA | BCL2L12 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.007 |
mRNA | C4orf26 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
mRNA | LIMA1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
mRNA | GCSH | CTRPv2 | pan-cancer | AAC | -0.092 | 0.007 |